Co-Diagnostics (CODX +15.3%) is up on almost double normal volume on the heels of its announcement that
its Research-Use-Only (RUO) CoPrimer test for 2019-nCov, the
coronavirus causing the current outbreak, is ready for sale to qualified
laboratories, hospitals and institutions.
https://seekingalpha.com/news/3539385-co-diagnostics-ruo-test-for-coronavirus-now-available-shares-up-15
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.